House bill · 119th Congress
Stop Chinese Fentanyl Act of 2025H.R. 747
Introduced by
- Introduced
- January 28, 2025
- Started in
- House
- Topic
- International Affairs
- Cosponsors
- 9
- Latest action
- September 3, 2025: Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
What the bill does
Summary written by the Congressional Research Service, Congress's nonpartisan research office, for the version marked "Introduced in House" (January 28, 2025).
Stop Chinese Fentanyl Act of 2025
This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking.
Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.
Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)
The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.
Recorded votes on this bill
Every roll-call vote taken on it, newest first. Each links to the official record of how every member voted.
| Date | Chamber | What was voted on | Outcome |
|---|---|---|---|
| September 2, 2025 | House | On Motion to Suspend the Rules and Pass, as Amended | Passed 407 yes, 4 no Official record |
Source: Voteview (UCLA), compiled from House Clerk and Senate roll-call records (retrieved November 21, 2026); U.S. Senate (retrieved November 21, 2026).
Cosponsors (9)
Members who signed on to support the bill, with the date each signed on.
Zachary NunnRepublican · IA · original cosponsor, January 28, 2025
Gregory F. MurphyRepublican · NC · original cosponsor, January 28, 2025
Michael LawlerRepublican · NY · March 10, 2025
Tim MooreRepublican · NC · March 25, 2025
Young KimRepublican · CA · April 8, 2025
Anna Paulina LunaRepublican · FL · April 8, 2025
Robert P. BresnahanRepublican · PA · May 5, 2025
Chris PappasDemocratic · NH · August 29, 2025
Laura GillenDemocratic · NY · September 2, 2025
Every step it has taken
Each action recorded on the bill, newest first.
- September 3, 2025 · Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- September 2, 2025 · Motion to reconsider laid on the table Agreed to without objection.
- September 2, 2025 · On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
- September 2, 2025 · Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
- September 2, 2025 · Considered as unfinished business. (consideration: CR H3741-3742)
- September 2, 2025 · At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- September 2, 2025 · DEBATE - The House proceeded with forty minutes of debate on H.R. 747.
- September 2, 2025 · Considered under suspension of the rules. (consideration: CR H3728-3731)
Show all 16 steps
- September 2, 2025 · Mr. Baumgartner moved to suspend the rules and pass the bill, as amended.
- April 9, 2025 · Ordered to be Reported in the Nature of a Substitute by Voice Vote.
- April 9, 2025 · Committee Consideration and Mark-up Session Held
- March 21, 2025 · Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
- March 5, 2025 · Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- March 5, 2025 · Committee Consideration and Mark-up Session Held
- January 28, 2025 · Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- January 28, 2025 · Introduced in House
Read the bill
- Referred in Senate · September 3, 2025
- Engrossed in House · September 2, 2025
- Introduced in House · January 28, 2025
Full text on GovInfo, the government's official publisher.
What it would cost
- H.R. 747, Stop Chinese Fentanyl Act of 2025As reported by the House Committee on Financial Services on March 21, 2025 · April 1, 2025
- H.R. 747, Stop Chinese Fentanyl Act of 2025As ordered reported by the House Committee on Foreign Affairs on April 9, 2025 · May 22, 2025
Estimates by the Congressional Budget Office.
Source: U.S. Government Publishing Office (GovInfo), from the Library of Congress bill status record (retrieved November 22, 2026). Read live from GovInfo's bill status record, the same record behind Congress.gov, the moment this page is opened.